Clinical data | |
---|---|
Routes of administration | Oral |
ATC code |
|
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.036.150 ![]() |
Chemical and physical data | |
Formula | C12H17ClO2 |
Molar mass | 228.72 g·mol−1 |
Fenpentadiol (INN) (brand names Tredum, Trefenum; developmental code name Rd-292), also known as phenpentanediol, is a drug described as a tranquilizer and antidepressant that was formerly marketed in Europe.[1][2] It also has stimulant, sedative, and anxiolytic effects, with the latter two occurring only at higher doses.[3][4]
The following literature incidence of the fenpentadiol has been found and quoted:
In three articles the properties of a new psychotropic agent from the series of araliphatic alcohols — phenpentanediol (CXV) — were described (477-479). It is not easy to place this substance anywhere in the pharmacodynamic system of psychotropic agents: on the one hand it potentiates the barbiturate narcosis, on the other it increases motility and exploratory activity in mice and potentiates the effects of amphetamine.
— Farmaco. Edizione Scientifica. 1974. p. 90.
| |||||||||||||||||||||
| |||||||||||||||||||||
| |||||||||||||||||||||
|
5-HT1AR agonists | |
---|---|
GABAAR PAMs |
|
Gabapentinoids (α2δ VDCC blockers) | |
Antidepressants |
|
Sympatholytics (Antiadrenergics) |
|
Others | |
|